In the news

  • Article title

    Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer

  • Article title

    Serological biomarkers in triage of FIT-positive subjects?

  • Article title

    Cameron Reynolds on Stock Tube, March 2017

  • Article title

    Share Radio catches up with Volition's CEO Cameron Reynolds

  • Article title

    Cameron Reynolds on Danish News

  • Article title

    VolitionRx chief hails importance of colorectal cancer screening test CE mark

  • Article title

    Edison TV interview with Cameron Reynolds

  • Article title

    Share Radio - Revolutionising cancer diagnosis: Greenlight given for new blood test

  • Article title

    audioBoom - Revolutionising cancer diagnosis: Greenlight given for new blood test

  • Article title

    VolitionRx Investor Presentation at The Richmond Club, Toronto

arrow-down arrow-left arrow-right arrow chevron-down circle-link--red circle-link close play plus